Virtu Financial LLC Viatris Inc Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$11.27 - $13.53 $115,472 - $138,628	10,246 New	10,246 $122,000
Q2 2023 Jul 27, 2023	SELL	$9.02 - $10.29 $173,021 - $197,382	-19,182 Reduced 53.26%	16,832 $168,000
Q1 2023 May 01, 2023	BUY	$9.2 - $12.26 $105,956 - $141,198	11,517 Added 47.01%	36,014 $346,000
Q4 2022 Feb 15, 2023	BUY	$8.72 - $11.56 $213,613 - $283,185	24,497 New	24,497 $273,000
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $1.02 Million - $1.26 Million	-102,598 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$9.81 - $15.4 $1.01 Million - $1.58 Million	102,598 New	102,598 $1.12 Million
Q4 2021 Feb 17, 2022	SELL	$12.09 - $14.68 $955,944 - $1.16 Million	-79,069 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $1.05 Million - $1.2 Million	79,069 New	79,069 $1.07 Million

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.